» Articles » PMID: 37868258

An Observational Study on Carbapenem-resistant Enterobacterales (CRE) Colonisation and Subsequent Risk of Infection in an Adult Intensive Care Unit (ICU) at a Tertiary Care Hospital in India

Overview
Date 2023 Oct 23
PMID 37868258
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Carbapenem-resistant Enterobacterales (CRE) are a global health problem with a growing prevalence. India has a high prevalence of CRE. CRE infections are difficult to treat, and are associated with significant morbidity and mortality. Colonisation is generally a prerequisite for infection and the prevention of CRE colonisation is key to the prevention of CRE infection.

Objectives: To determine the prevalence of CRE colonisation and subsequent infections in an adult intensive care unit (ICU) in India.

Methods: We conducted a prospective observational study in which perirectal swabs were obtained along with relevant clinical details of consenting adult patients upon ICU admission between January 2019 and August 2020. Rectal screening was performed using MacConkey agar plates with ertapenem disks and further identification was performed using conventional microbiological techniques. Ertapenem minimum inhibitory concentration (MIC) was determined using an epsillometer (E) test. The modified carbapenem inactivation (mCIM) test and EDTA carbapenem inactivation test (eCIM) were performed to confirm carbapenem resistance using the Clinical Laboratory Standards Institute (CLSI) 2020 guidelines.

Results: 192 ICU patients were screened for CRE. 37 patients were found to be colonised with CRE. (=25; 67.6%) was the most frequent CRE isolate, followed by (11; 29.7%) and one (1; 2.7%). 89.2% (33/37) patients developed CRE infection. Pneumonia was the most common CRE infection identified in 12/33 (36.4%) patients.during the hospital stay. The median duration of hospital stay was longer (17 days) for CRE colonised compared to CRE non-colonised patients (9 days) (<0.001). Death occurred in 27 % (10/37) of CRE-colonised patients during the hospital admission.

Conclusion: CRE colonisation is associated with high risk of subsequent CRE infection and longer ICU and hospital admission.

Citing Articles

Outcomes of Living Donor Liver Transplantation in Recipients Colonized With Carbapenem-Resistant Enterobacterales.

Rajakumar A, Ramanan P, Sam A, Devarajan V, Sundaramoorthy S, Jothimani D J Clin Exp Hepatol. 2025; 15(4):102508.

PMID: 40040928 PMC: 11872560. DOI: 10.1016/j.jceh.2025.102508.


Risk Factors Analysis and Prediction Model Establishment for Carbapenem-Resistant Enterobacteriaceae Colonization: A Retrospective Cohort Study.

Guo X, Wu D, Chen X, Lin J, Chen J, Wang L Infect Drug Resist. 2024; 17:4717-4726.

PMID: 39494229 PMC: 11529608. DOI: 10.2147/IDR.S485915.


Gut colonization with multidrug resistant organisms in the intensive care unit: a systematic review and meta-analysis.

Heath M, Fan W, Leu C, Gomez-Simmonds A, Lodise T, Freedberg D Crit Care. 2024; 28(1):211.

PMID: 38943133 PMC: 11214232. DOI: 10.1186/s13054-024-04999-9.


Timing and clinical risk factors for early acquisition of gut pathogen colonization with multidrug resistant organisms in the intensive care unit.

Shamalov L, Heath M, Lynch E, Green D, Gomez-Simmonds A, Freedberg D Gut Pathog. 2024; 16(1):10.

PMID: 38383457 PMC: 10880254. DOI: 10.1186/s13099-024-00605-z.

References
1.
Datta P, Gupta V, Singla N, Chander J . Asymptomatic colonization with carbapenem resistant enterobacteriaceae (CRE) in ICU patients and its associated risk factors: Study from North India. Indian J Med Microbiol. 2015; 33(4):612-3. DOI: 10.4103/0255-0857.167316. View

2.
Tran D, Larsson M, Olson L, Hoang N, Le N, Khu D . High prevalence of colonisation with carbapenem-resistant Enterobacteriaceae among patients admitted to Vietnamese hospitals: Risk factors and burden of disease. J Infect. 2019; 79(2):115-122. DOI: 10.1016/j.jinf.2019.05.013. View

3.
Carlet J . The gut is the epicentre of antibiotic resistance. Antimicrob Resist Infect Control. 2012; 1(1):39. PMC: 3554492. DOI: 10.1186/2047-2994-1-39. View

4.
Nordmann P, Poirel L . Strategies for identification of carbapenemase-producing Enterobacteriaceae. J Antimicrob Chemother. 2012; 68(3):487-9. DOI: 10.1093/jac/dks426. View

5.
Asai N, Sakanashi D, Suematsu H, Kato H, Hagihara M, Nishiyama N . The epidemiology and risk factor of carbapenem-resistant enterobacteriaceae colonization and infections: Case control study in a single institute in Japan. J Infect Chemother. 2018; 24(7):505-509. DOI: 10.1016/j.jiac.2018.02.005. View